Compare · 2 funds side by side · dividends reinvested

CURE and VIG

CUREDirexion×VIGVanguard×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$16,331VIG · best of the two

02 / 04

CURE and VIG, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

Vanguard Dividend Appreciation ETFIncome · Dividend stocks0.04%1.49%+12.5%+15.2%+18.9%+10.3%−7.9%10.8%$109B1.4

Direxion Daily Healthcare Bull 3X ETFLeveraged · 3x0.94%0.76%+50.8%+81.4%+29.9%+7.9%−31.1%49.4%$201M1.6

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 5, 2026 · returns include dividends · since: CURE 2011 · VIG 2006

Head to Head

Swap sides Versus in desk

Head to Head

Direxion Daily Healthcare Bull 3X ETF · $201M$14,647

CURE

VIG

Vanguard Dividend Appreciation ETF · $109B$16,331

$10,000 five years ago, dividends reinvested · they hold 13.7% in common

CUREMeasureVIG

+50.8%Year to dateJan 1 → Nov 5+12.5%

+81.4%1 yearTotal return+15.2%

+29.9%3 years · per year$10,000 became $21,930 · $16,814+18.9%

+7.9%5 years · per year$10,000 became $14,647 · $16,331+10.3%

0.94%Expense ratio$94 · $4 a year on $10k · lower is better0.04%

0.76%Trailing 12-mo yield$76 · $149 a year on $10k1.49%

−31.1%Worst dropSmaller is better−7.9%

49.4%VolatilityLower is calmer10.8%

CUREVIG Winner of the row, in its colourEach row: the bigger of the two fills its side

3–5VIG wins

End-of-day Nov 5, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

CURE vs VIG: Top 5 Holdings

Today

CURE

8.9%in top 5

VIG

in top 522.1%

CUREStockVIG

not top 5MSFT4.9%

not top 5AAPL4.9%

not top 5AVGO4.3%

3.3%LLY4.1%

not top 5JPM3.9%

1.9%JNJnot top 5

1.5%ABBVnot top 5

1.1%MRKnot top 5

1.1%UNHnot top 5

Held in common13.7%

End-of-day Nov 5, 2026 · share of each fund

CURE vs VIG Returns, Every Period

DirexionCURE

+7.9%

5 years, per year

VIGVanguard

+10.3%

5 years, per year

CUREVIGFaded: behind in that period

3–1CURE wins

End-of-day Nov 5, 2026 · dividends in · faded = behind in that period

Leveraged vs Income: CURE vs VIG

YTD

DirexionCURE

+50.8%

VIGVanguard

+12.5%

+50.8%Year to date+12.5%

−31.1%Worst drop · 1Y−7.9%

49.4%Volatility · 1Y10.8%

0.8%Yield1.5%

$201MAssets$109B

3–1VIG wins

End-of-day Nov 5, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: CURE, VIG

Today

0.04%lowest, VIG

FundExpense ratioFee$10k

VIG0.04%$4

CURE0.94%$94

End-of-day Nov 5, 2026 · fee on $10,000 a year

Yields: CURE, VIG

1.49%highest, VIG

FundTrailing yieldYield$10k

VIG1.49%$149

CURE0.76%$76

End-of-day Nov 5, 2026 · trailing 12-month yield

Income After Fees on $10,000

$145most kept, VIG

VIG$149 − $4 = $145

CURE$76 − $94 = −$18

KeptFee

End-of-day Nov 5, 2026 · yield in dollars minus the fee

Overlap: CURE, VIG

Today

13.7%most shared, CURE and VIG

CUREVIG

CURE—13.7%

VIG13.7%—

End-of-day Nov 5, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+81.4%CURE, at 49.4% volatility

VIGWorst drop−7.9%10.8% vol

CUREWorst drop−31.1%49.4% vol

End-of-day Nov 5, 2026 · up and left is better

Paid More vs Made More

YTD

VIGCURE

+12.5%Year to date+50.8%

1.5%Yield0.8%

+15.2%Past year+81.4%

0.04%Fee0.94%

2–2level

End-of-day Nov 5, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.3%

VIGVanguard

+12.5%

+32.3%Year to date+12.5%

3.0%Yield1.5%

$123BAssets$109B

2–0SCHD wins

End-of-day Nov 5, 2026

DGRO vs VIG

YTD

iSharesDGRO

+17.2%

VIGVanguard

+12.5%

+17.2%Year to date+12.5%

1.9%Yield1.5%

$46.1BAssets$109B

2–0DGRO wins

End-of-day Nov 5, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+5.2%

+8.5%Year to date+5.2%

12.2%Yield8.1%

$42.1BAssets$46.1B

2–0JEPQ wins

End-of-day Nov 5, 2026